PUK20 A COST EFFECTIVENESS ANALYSIS OF SOLIFENACIN COMPARED WITH EXTENDED-RELEASE TOLTERODINE FOR THE TREATMENT OF OVERACTIVE BLADDER
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65151-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)65151-0/fulltext
Section Title :
Section Order :
310
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65151-0&doi=10.1016/S1098-3015(10)65151-0